The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
These drugs must be administered by intravenous (by vein) infusion or by an injection, and they are more expensive than other arthritis drugs.
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...
LOVELAND, CO, UNITED STATES, January 29, 2025 /EINPresswire / -- The newly opened Suite Health infusion clinic provides personalized infusion therapy options for clients seeking targeted infusion ...
When people walk into the outpatient infusion clinic, they're greeted with a warm and comfortable environment.
Denver Location Boasts Private Infusion Suites for Addressing Patients’ Specialty Therapy Needs Soleo Health, an innovative ...